global glp-1 obesity drug market size forecast 2030 Weight Loss Drugs & Share Report 2026-2030 GLP-1 Weight-Loss Drugs Ride Health,

in the other outcome, the injured tissue continues to deteriorate, and the mechanism of the persisting damage involves gliosis with the loss of support of neurotrophic factors, persistent inflammatory receptor activation, and changes in microglia and astrocytes that continue to release harmful cytokines, which promote neuronal death and axonal injury

Using available data, keeping the balance between excretion and overproduction of SUA is reasonable for prevention and management of gout

Antibiotic alleviates radiation-induced intestinal injury by remodeling microbiota, reducing inflammation, and inhibiting fibrosis

No separation or washing is required

Kim Y, Bae JM, Huh G